FDA

How Many COVID Shots Will US Need? FDA Panel to Discuss What's Ahead for Fall

The panel meets Wednesday as some experts question whether getting additional doses every few months is a practical public health strategy

Moderna Covid-19 vaccine
Simon Maina | AFP | Getty Images

Food and Drug Administration advisers will meet Wednesday to hash out what the future of COVID-19 boosters will look like in the United States.

It's a question that looms large: Just a week ago, the FDA and the Centers for Disease Control and Prevention signed off on a second booster dose for people ages 50 and up, four months after their first booster.

STAY IN THE KNOW

icon

Watch NBC10 Boston news for free, 24/7, wherever you are.

icon

Get Boston local news, weather forecasts, lifestyle and entertainment stories to your inbox. Sign up for NBC Boston’s newsletters.

But fewer than half of eligible adults have even received that first booster shot, and some health experts question whether getting additional doses of the vaccines every few months to protect against mild illness is a practical public health strategy.

The all-day meeting Wednesday of the agency’s Vaccines and Related Biological Products Advisory Committee will try to answer these questions, or at least develop a framework for a long-term booster strategy, according to briefing documents released by the FDA before the meeting.

Read the full story on NBCNews.com here

Contact Us